(Q43770941)

26 November 2017

title

DNA interaction and cytotoxicity of a new series of indolo[2,3-b]quinoxaline and pyridopyrazino[2,3-b]indole derivatives (English)

1 reference

26 November 2017

0 references

Arimondo PB

1

1 reference

26 November 2017

Baldeyrou B

2

1 reference

26 November 2017

Laine W

3

1 reference

26 November 2017

Bal C

4

1 reference

26 November 2017

Alphonse FA

5

1 reference

26 November 2017

Routier S

6

1 reference

26 November 2017

Coudert G

7

1 reference

26 November 2017

Mérour JY

8

1 reference

26 November 2017

Colson P

9

1 reference

26 November 2017

Houssier C

10

1 reference

26 November 2017

Bailly C

11

1 reference

26 November 2017

publication date

1 October 2001

1 reference

Chemico-biological Interactions

26 November 2017

published in

1 reference

26 November 2017

volume

138

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

59-75

1 reference

Structural considerations in the interaction of DNA and acridines

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

The structure of the DNA-acridine complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Interaction of ellipticine and an indolo[2,3b]-quinoxaline derivative with DNA and synthetic polynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

1H-NMR studies of the interaction between a self-complementary deoxyoligonucleotide duplex and indolo[2,3-b]quinoxaline derivatives active against herpes virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

The interaction of ellipticine derivatives with nucleic acids studied by optical and 1H-nmr spectroscopy: effect of size of the heterocyclic ring system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Interactions of the antiviral quinoxaline derivative 9-OH-B220 {2,3-dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6H-indolo-[2,3-b]quinoxaline} with duplex and triplex forms of synthetic DNA and RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Electric linear dichroism as a new tool to study sequence preference in drug binding to DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Comparison of different footprinting methodologies for detecting binding sites for a small ligand on DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Sequence-selective binding of an ellipticine derivative to DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2801%2900260-5

10.1016/S0009-2797(01)00260-5

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference